Medical Articles 8/30

Posted by rob on August 30, 2008 under Uncategorized | Be the First to Comment

Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.

Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.

Dasatinib dosing strategies in Philadelphia chromosome-positive leukemia.

Treating refractory leukemias in childhood, role of clofarabine.

Developmental stage-related expression and identification of murine erythroid differentiation-denucleation factor (MEDDF).

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia.

Novel iron complexes bearing N6-substituted adenosine derivatives: Synthesis, magnetic, (57)Fe Mössbauer, DFT, and in vitro cytotoxicity studies.

A case of chronic myelogenous leukemia with e8a2 fusion transcript.

Deep discount prices on portable generators at http://generatorzoo.com

Medical Articles 8/23

Posted by rob on August 23, 2008 under Uncategorized | Be the First to Comment

body { border-style: none; background: Window; color: WindowText; } #ljcutbegin { width: 100%; height: 1px; border: 1px dashed black; } #ljcutend { width: 100%; height: 1px; border: 1px dashed gray; } }

Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.

[Expression and Analysis of HLA-A, B and DRB1 Genes in Patients with Chronic Myelogenous Leukemia in Guangdong Area.]

[Establishment of the methods to detect nucleophosmin gene and its mutation in acute myelogenous leukemia.]

[Expression of A Tumor Related Gene fgfr3 mRNA in Leukemic Cells and its Clinical Significance.]

[SphK-1/S1P Signal Pathway in CML Cells.]

Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells.

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells.

Deep discount prices on Dewalt generators at GeneratorZoo.Com

Medical Articles 8/20

Posted by rob on August 20, 2008 under Uncategorized | Be the First to Comment

Modern approaches to treating chronic myelogenous leukemia.

Enhanced
therapeutic effects on the multi-drug resistant human leukemia cells in
vitro and xenograft in mice using the stealthy liposomal vincristine
plus quinacrine.

[Protein kinase C inhibitor Gö6976 sensitizes arsenic trioxide-induced cell apoptosis in chronic myeloid leukemic cells]

[STI571 used in treating acute myeloid leukemia with Philadelphia chromosome]

Medical Articles 8/15

Posted by rob on August 15, 2008 under Uncategorized | Be the First to Comment

[Nosocomial respiratory syncytial virus infections in three cases in a bone marrow transplantation unit]

Proteomic
analysis of an imatinib-resistant K562 cell line highlights opposing
roles of heat shock cognate 70 and heat shock 70 proteins in resistance.

Imatinib
for newly diagnosed patients with chronic myeloid leukemia: incidence
of sustained responses in an intention-to-treat analysis.

Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia.

Medical Articles 8/13

Posted by rob on August 13, 2008 under Uncategorized | Be the First to Comment

Flow
cytometric assay of phosphotyrosine levels in Bcr-Abl-positive chronic
myelogenous leukemias: a potential prognostic marker.

Inhibition
of Polysome Assembly Enhances Imatinib Activity Against Chronic
Myelogenous Leukemia, and Overcomes Imatinib Resistance.

Medical Articles 8/9

Posted by rob on August 9, 2008 under Uncategorized | Be the First to Comment

Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.

Advanced CML: therapeutic options for patients in accelerated and blast phases.

Beyond dose escalation: clinical options for relapse or resistance in chronic myelogenous leukemia.

Resistance and relapse with imatinib in CML: causes and consequences.

First-Line management of CML: a state of the art review.

Fusion
of circulating blood cells with solid-organ tissue cells in clinical
stem cell transplants: a potential therapeutic model?

Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells.

Medical Articles 8/8

Posted by rob on August 8, 2008 under Uncategorized | Be the First to Comment

Loss of the Y chromosome: an age-related or clonal phenomenon in acute myelogenous leukemia/myelodysplastic syndrome?

Current status of therapy for chronic myeloid leukemia: a review of drug development.

Simultaneous occurrence of t(9;22)(q34;q11.2) and t(16;16)(p13;q22) in a patient with chronic myeloid leukemia in blastic phase.

Medical Articles 8/5

Posted by rob on August 5, 2008 under Uncategorized | Be the First to Comment

Inhibitors of ABL and the ABL-T315I Mutation.

Management of late CML relapse.

The proto-oncogene expression varies over the course of chronic myeloid leukemia.

Prolonged
molecular remission in advanced phase of chronic myeloid leukemia using
combination of imatinib and high-dose chemotherapy.

JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera.

Possible
role for gene expression profiling in predicting responses to
conventional or targeted drugs in patients with chronic myeloid
leukemia.

Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemia.

Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.

New therapeutic approaches and prognostic factors in chronic myeloid leukemia.

Medical Articles 8/3

Posted by rob on August 3, 2008 under Uncategorized | Be the First to Comment

Labial fusion: a rare complication of chronic graft-versus-host disease.

Progressive multifocal leukoencephalopathy in a patient with relapsed acute myelogenous leukemia.

Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia.

Pleural effusions in patients with chronic myeloid leukaemia treated with dasatinib may have an immune-mediated pathogenesis.

Chronic myeloid leukemia presenting as vulvar hematoma.

Medical Articles 8/2

Posted by rob on August 2, 2008 under Uncategorized | Be the First to Comment

Coronary thrombosis in a patient with leukemic thrombocytosis: which was the best treatment?

High
expression of CD7 on CD34+ cells is not linked to deletion of
derivative chromosome 9 or lack of dendritic cells in chronic myeloid
leukaemia.

[Association between HLA and leukemia in a mixed Brazilian population]

home top